Skip to main content
Nicholas Shelburne, MD, Pulmonology, Oklahoma City, OK

NicholasShelburneMD

Pulmonology Oklahoma City, OK

Physician

Dr. Shelburne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shelburne's full profile

Already have an account?

  • Office

    3400 NW Expressway St
    Oklahoma City, OK 73112

Summary

  • Dr. Nicholas Shelburne is a pulmonology specialist based in Nashville, TN. He graduated from Vanderbilt University School of Medicine in 2016. His recent publications focus on pulmonary hypertension, with research articles featured in journals such as CHEST, American Journal of Respiratory and Critical Care Medicine, and Pulmonary Circulation. His work includes topics like the impact of male sex on right ventricular function, prostaglandin therapy in pulmonary arterial hypertension, and methods for optimizing risk stratification in these patients. His publications have been cited by other works, indicating engagement with the scholarly community.

Education & Training

  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2016

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2023 - 2025
  • TN State Medical License
    TN State Medical License 2020 - 2024
  • NC State Medical License
    NC State Medical License 2016 - 2019
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated Awards
    Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated AwardsSeptember 10th, 2021